742.31MMarket Cap-2272P/E (TTM)
2.020High1.870Low1.35MVolume1.990Open1.990Pre Close2.64MTurnover0.57%Turnover RatioLossP/E (Static)371.15MShares3.05052wk High1.45P/B470.12MFloat Cap1.21052wk Low--Dividend TTM235.06MShs Float49.455Historical High--Div YieldTTM7.54%Amplitude0.920Historical Low1.955Avg Price1Lot Size
Standard BioTools Stock Forum
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet